Biotin link to cancer cells, Pg14

Key Highlights:

• Researchers at the University of Lausanne discovered that vitamin B7 (Biotin) enables cancer cells to use alternative fuels.
• Biotin acts as a metabolic "license," allowing cancer cells to bypass their "glutamine addiction".
• Without biotin, cancer cells lose metabolic flexibility and their growth is inhibited.
• Mutations in cancer-linked genes can amplify this vulnerability, creating a potential new target for cancer therapy.

Detailed Insights:

• Cancer cells often exhibit a dependence on glutamine, but can develop alternative metabolic pathways to survive.
• Biotin is essential for the activity of enzymes like acetyl-CoA carboxylase (ACC), which is crucial for fatty acid synthesis.
• Inhibiting biotin could prevent cancer cells from switching to alternative metabolic pathways, making them more susceptible to treatment.
• This research may explain why therapies targeting glutamine metabolism alone are not always effective in treating cancer.

Scientific/Technical Concepts Involved:

• Biotin (Vitamin B7): A water-soluble vitamin that acts as a cofactor for several metabolic enzymes.
• Glutamine Addiction: The dependence of cancer cells on the amino acid glutamine for energy and growth.
• Metabolic Pathway: A series of chemical reactions occurring within a cell, involving enzymes and substrates.